Health News   Health Library   Health Topics   Healthy Living   HealthLink
Today's Headlines    Health Alerts    Health News Feature   
Future of Medicine    Health Observances    Product Recalls
Illnesses & Conditions    Drug Guide    FDA Drug Approvals    Complementary Medicine    Medical Tests   
Self-Help Resources    Medline Search
Allergies    Asthma    Back Pain    Cancer    Caregiver    Depression    Diabetes    Digestive Disorders
Heart Disease    Kidney Disease    Men's Health    Parenting    Pregnancy    Senior's Health
Stress    Stroke    Women's Health
Fitness    Nutrition    Mind & Body    Family & Home







'Lighting Up' Asthma
 Asthma Center Feature Story

'Lighting Up' Asthma
Helium-MRI combination gives a better image of the lungs

(HealthDay News) – One of the major problems with determining the severity of asthma and other lung diseases has been scientists' inability to see how well the small passages of the lungs are working. That problem is on its way to resolution, literally.

A new magnetic resonance imaging (MRI) technique that uses specially treated helium to light up the lungs' airways may be the way to decide types of asthma treatment.

The technique, called dynamic hyperpolarized 3He (helium) imaging, is the first method able to provide clear resolution of the smaller lung airways. It could help doctors better understand and treat asthma and other chronic obstructive pulmonary diseases (COPD). Helium is an inert gas that can be inhaled directly into the lungs with no adverse reaction. Hyperpolarized helium lights up when viewed through an MRI.
Researchers at Brigham and Women's Hospital in Boston had six healthy adult volunteers, aged 22 to 40, inhale one breath of hyperpolarized helium gas at the same time that they were undergoing an MRI. The images using this method showed contrast of both distal airways (those smaller passages of the lung leading away from the main branches) and the lung periphery. Results appeared in the May 2003 issue of Radiology.

"Other non-radioactive techniques have only been able to image lung peripheries. Dynamic hyperpolarized helium MR imaging offers a completely noninvasive and safe method of studying the airways," principal investigator Mitchell S. Albert said in a news release at the time the research was published.

"Our new technique provides information on ventilation, while depicting structure and function of the airways. Other non-radioactive imaging modalities do not provide this type of information," Albert added.

If the hyperpolarized helium/MRI method can be used to help determine asthma treatment, it also could be used as a diagnostic tool for other COPD diseases. And there are many. According to the U.S. government's National Heart, Lung, and Blood Institute, chronic obstructive pulmonary disease is the fourth leading cause of death in the United States and in the world.

Here is the institute's description of how various activities such as cigarette smoking can lead to COPD:

Cigarette smoking is the most common cause of COPD. Most people with COPD are smokers or former smokers. Breathing in other kinds of lung irritants, like pollution, dust, or chemicals over a long period of time may also cause or contribute to COPD.

At the end of each airway branch are many small, balloon-like air sacs. In healthy people, each airway is clear and open, the air sacs are small and dainty, and both are elastic and springy. When you breathe in, each air sac fills up with air, like a small balloon, and when you breathe out, the balloon deflates and the air goes out.

In COPD, the airways and air sacs lose their shape and become floppy. Less air gets in and less air goes out because:

• 

The airways and air sacs lose their elasticity (like an old rubber band);

• 

The walls between many of the air sacs are destroyed;

• 

The walls of the airways become thick and inflamed (swollen);

• 

Cells in the airways make more mucus (sputum) than usual, which tends to clog the airways.

COPD develops slowly, and it may be many years before you notice symptoms like feeling short of breath. Most of the time, COPD is diagnosed in middle-aged or older people.
Chronic obstructive pulmonary disease has no cure, but there are treatments that can help, according to the institute.

Bronchodilators

Your doctor may recommend medications called bronchodilators that work by relaxing the muscles around the airways. They help open the airways quickly and make breathing easier. Bronchodilators can be either short-acting or long-acting.

• 

Short-acting bronchodilators last about 4 to 6 hours and are used only when needed.

• 

Long-acting bronchodilators last about 12 hours or more and are used every day.

Most bronchodilator medications are inhaled so they go directly into the lungs, where they are needed. There are many kinds of inhalers, and it is important to know how to use an inhaler correctly.

If you have mild COPD, your doctor may recommend that you use a short-acting bronchodilator. You then will use the inhaler only when needed.

If you have moderate or severe COPD, your doctor may recommend regular treatment with one or more inhaled bronchodilators. You may be told to use one long-acting bronchodilator. Some people may need to use a long-acting bronchodilator and a short-acting bronchodilator. This is called combination therapy.

Inhaled Glucocorticosteroids (Steroids)

Inhaled steroids are used for some people with moderate or severe COPD. Inhaled steroids work to reduce airway inflammation. Your doctor may recommend that you try inhaled steroids for six weeks to three months to see if the medication helps with your breathing problems.

On the Web

The American College of Allergy, Asthma & Immunology has information on screening for asthma. To learn more about asthma, visit the National Heart, Lung, and Blood Institute.

SOURCES:
Article, Radiology, May 2003; |
Radiological Society of North America, news release, April 29, 2003;
Articles, National Heart, Lung, and Blood Institute, updated April 18, 2004
Publication date: May 31, 2004
Copyright © 2004 ScoutNews, LLC. All rights reserved.
Author: Barry Hoffman



Powered by Healthvision